interesting - search results

If you're not happy with the results, please do another search

0 472

Medbox’s Largest Shareholder Comments on Recent Events and the Company’s Outlook for 2015

LOS ANGELES, CA–(Marketwired – Dec 30, 2014) – P. Vincent Mehdizadeh — Founder and Majority Shareholder of Medbox, Inc. (OTCQB: MDBX) issued a letter to fellow shareholders today regarding his vision for the future of the company and insight into recent developments affecting the company.

The letter stated:

“Dear Medbox Shareholders:

It has truly been an interesting journey during the last 2 years. When I commenced operations of the private company in 2010 that later became Medbox, I never anticipated that the company would be as noteworthy and relevant as we are today. The company has a rare blend of consulting and patented technology that gives entrepreneurs a jumpstart on realizing their dreams of operating a business in a newly emerging industry. I have thoroughly enjoyed watching our client’s dreams be realized, along with our shareholders that have watched our company grow and prosper over these years.

Medbox rocketed to stardom and notoriety amidst a positive outlook for the marijuana industry in November of 2012 based on favorable election results and highlighted by several media sources, including the Wall Street Journal, which ushered in what many have called the ‘Green Rush.’ In the days that followed, the company’s stock price saw unprecedented increases that was said to have resulted from investors looking to participate in ‘The Next Great American Industry.’ Up until 3 months ago, I was involved in almost every decision the company made, and my decision at that time was to caution investors about investing in any company in the marijuana industry because of the inherent risks. We also publicly cautioned investors to temper their expectations about our stock and to make informed investment decisions. The company fielded criticism in doing so, but we felt that separating ourselves from other public company industry participants in our sector and focusing on protecting investors as best we could was a beneficial direction for the company. In my opinion, one of the keys to Medbox’s success has been superior corporate messaging and timely dissemination of information to our shareholders.

Since that point in time a little over two years ago, I have made it my mission to take the company from being a non-reporting pinksheet to being a fully reporting SEC Filer. I took it upon myself to set these goals and achieve them for the benefit of the company and its shareholders. We did this to have an increased level of transparency so that investors can think of Medbox as the public company standard for respectability and reliability in the newly emerging marijuana industry that was taking shape. As a result, we engaged a Public Company Accounting and Oversight Board (PCAOB) registered auditor, Q Accountancy Corporation, and also hired a full-time Chief Financial Officer, Thomas Iwanski, a CPA with excellent references and extensive public company experience.

Since the company engaged Mr. Iwanski and Q Accountancy Corporation, I also recruited a star-studded board and together we appointed Guy Marsala to lead the company as the Chief Executive Officer. As it was explained to me, in situations where a new CEO is brought on, they typically look to appoint their own Chief Financial Officer. Thus, when Mr. Marsala decided to replace Mr. Iwanski as CFO, I did not give it a second thought, although I was sad to see him go since his experience with public company oversight was superb.

Today, the company’s current management issued a statement regarding the company’s financials. Prior management, including Mr. Iwanski and the company’s current auditor, both disagree with current management’s position on the matter. Both the current auditor and prior CFO have made their opinions known to current management, to no avail. Both have stated that they had support for recognizing revenue in the periods in which they were recognized. However, the company’s current CFO has a difference of opinion on that aspect and believes that the revenue in question should be recognized in later periods, which has now resulted in a proposed restatement set to occur. This fact along with the fact that the revenue items in dispute amount to less than 10% of the total revenue booked for 2013, was not accurately discussed in the disclosure released this morning. 

As stated previously in this letter, corporate messaging and communication to shareholders is one of the many aspects that made Medbox a great company. I now feel the company is not doing enough to accurately disclose matters in a manner that is easy to understand and digest by the public. Stating that the current CFO has a difference of opinion with the prior CFO and current auditor would have gone a long way to explaining the situation properly. Instead, we have the inaccurate and incomplete disclosure that was released today that leaves the public with more questions than giving them the answers they need to understand the situation.

As we were on a path to transition to NASDAQ and had filed an application to be listed on that exchange, I felt that since I had a checkered past that was disclosed in company filings it would tarnish the Medbox brand if I stayed involved in any capacity other than as a consultant to the company. Although these offenses were non-violent, non-securities related offenses, all of which resulted in probation and all occurring prior to Medbox, I still felt that the company would always be a target of ‘short and distort’ campaigns by financial bloggers if I remained an Officer or Director. To that end, I recently gave full control to the board and current management to steer the ship and navigate the company properly. Recent events have caused me to call into question whether current management and the board of directors has enough industry experience to properly run this company. It is for this reason that I will be adding industry-experienced members to the board to work with the current board members to more effectively operate the company. I will also be taking a more active role with the company again to ensure our short-term and long-term goals can be achieved.

I believe that a founder’s passion separates a typical company from a company that achieves the utmost success. The company needs my help now more than ever, and I intend to fill that need to the best of my ability going forward. I look forward to a strong and prosperous future for Medbox.


P. Vincent Mehdizadeh”

About P. Vincent Mehdizadeh, Founder and Majority Shareholder at Medbox, Inc.
P. Vincent Mehdizadeh founded Medbox’s main subsidiary, Medicine Dispensing Systems, in February 2008. He commenced operations for that company in 2010, and in December of 2011 sold that company to what became Medbox, Inc. Mr. Mehdizadeh served as senior consultant from December 2012 until May 10, 2013 for Medbox, Inc. and then transitioned to Chief Operations Officer and Board Chairman for Medbox, Inc. through May of 2014. Mr. Mehdizadeh was responsible for creating the 2 main patents behind the company’s technology, helping to assemble the talented management team at Medbox, and also developing the concept behind the business models driving revenue for the company.

About Medbox, Inc:
Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Headquartered in Los Angeles, Medbox, through its wholly owned subsidiary, Medicine Dispensing Systems, offers their patented systems, software and consulting services to pharmacies, alternative medicine dispensaries and local governments in the U.S. In addition, through its wholly owned subsidiary, Vaporfection International, Inc. (, the company offers an industry award winning medical vaporizer product. Medbox, through its newly established subsidiaries, is in development of the following ancillary services catered to the alternative medicine industry: merchant services and armored transport for cash deposits, cannabidiol research and development, real estate acquisitions and subsequent lease programs to alternative medicine dispensaries, and alternative medicine dispensary management services.

Media Inquiries:
The Innovation Agency
Email Contact

0 423

SF’s Latest Innovation: A Weed of the Month Club

There has been a lot of controversy lately over people sending pot through the mail, which is a violation of federal law. This, of course, has prevented exceptionally interesting concepts like “Weed of the Month” clubs from realizing their full potential. However, one San Francisco-based business has found a solution to providing a monthly marijuana subscription box service by simply having its cannabis selections hand-delivered to the doors of stoners all across the city.

The company is called Marvina, which is a cannabis club that essentially provides patients holding a medical marijuana recommendation with a strain selection of the month. Just think Birchbox meets FTD flower delivery, and you will have a relatively decent grasp of what this company is attempting to accomplish.

For the full article click here.

0 236

Totally Hemp Crazy Inc. (THCZ) Preparing for Initial Product Run

THCZ to Produce Proprietary Hemp Beverage Line

DALLAS, Dec. 10, 2014 /PRNewswire/ — Totally Hemp Crazy Inc. (THCZ) today has announced that the packaging cans for the new product lines will be ready for final approval this month and then will go into production. The company expects that the cans will be produced and be ready to be shipped to the bottling company by January. The formulations for the beverages were finalized in November and their ingredients along with the proper bar codes were added to the cans’ final designs. The first products to be produced will be the Rocky Mountain High Hemp Iced Tea™, Rocky Mountain High Hemp Lemonade™ and Rocky Mountain High Hemp Energy Drink™. The second wave of hemp infused products to be launched into the marketplace will feature wine based alcoholic beverages (12.5% alcohol) in a 375ml PET flask. The target date for this launch is mid-spring 2015.

Rhino Marketing has completed their first phase of the initial rollout and has specified the initial retail target markets as Houston, Dallas, Austin and San Antonio.  Upon completion of the pilot markets the retail rollout will go nationwide.  A new and improved commerce version of the THCZ website designed by Rhino Marketing is almost complete and will be uploaded this month.  “We are really excited about how this product has progressed and we’re excited to be part of this great drink,” says Thomas Hensey, Rhino Marketing.

“We have raised capital from private placement funding and we are actively involved in negotiations with several other groups so we can produce a complete line of hemp based products that will in total be in excess of a dozen sku’s,” states Founder Jerry Grisaffi. “Several of the interested parties have some very interesting product ideas that will make 2015 a very exciting year for THCZ.  We will share these ideas with the investors upon the completion of the finance negotiations.  We do suggest that investors check the THCZ website on a regular basis as updates from this point on forward will be occurring on a regular basis.”  

Visit us at:

About Totally Hemp Crazy Inc.:

Our mission is to be the first total Hemp beverage company.

Safe Harbor Act: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

To view the original version on PR Newswire, visit:

0 748

By Michael Berger

Players Network Inc. (PNTV: OTCQB), is a diversified holding company that is focused on two primary industries, media and medical marijuana. PNTV offers investors the opportunity to invest in a diversified cannabis company that is levered to the legal Nevada marijuana market. PNTV is a one of the only fully reporting companies that has received a license to cultivate and process cannabis. This fact gives us a sense of confidence that PNTV is one of the more legitimate OTC traded marijuana stocks.

Entrance into the marijuana space

In late July, PNTV formed Green Leaf Farms Holdings, Inc. The company used Green Leaf to enter the legal medical marijuana industry and apply for a medical marijuana dispensary in Nevada. A few months later, Green Leaf’s application was approved by the state of Nevada for an edible extraction facility. The facility will be located on a 3.2 acre piece of property purchased by Green Leaf. The land which they purchased is able to support a 70,000 square foot facility which will easily be able to satisfy demand. PNTV owns 80% of Green Leaf Farms Holdings with the remaining 20 percent held by key advisors and experts.

The company is working diligently to hopefully commence operations by mid-2015. These operations will provide PNTV with a source of revenue that will enable the company to continue to grow and invest in profitable business ventures. The company believes that the facility can generate $12 to $14 million in annual revenue in its first year of operation. They expect total revenue generated by the facility to increase year over year as demand grows.

Unique business model can create synergies for their two business units

PNTV is also actively involved in the media industry through their proprietary channels. This offers the company another source of revenue, and free exposure for their marijuana business. The company will use, one of their proprietary channels to increase exposure for Green Leaf. This channel also generates revenues through advertising, cross selling with other companies and premium membership subscriptions.

The company has a unique advantage that makes them an interesting play in the cannabis space. PNTV is able to utilize their two businesses units to create synergies for each other and increase total revenues. These revenues will lead to higher margins, which will improve the company’s bottom line if they are able to execute on their business plan.

Strong management team

PNTV has been around since the early 1990s and they have created many strategic relationships that strengthen the company’s footprint. The company’s CEO and founder, Mark Bradley founded Players Network in 1993 and has served as CEO since the company’s inception. Bradley has been a producer/director at United Artists, and was studio manager and postproduction supervisor with United Cable Television in Los Angeles, engaged in the production, packaging and syndication of television and film productions for such media venues as HBO, Nickelodeon and MTV.

The company’s Chief Creative Officer, Michael Berk, is a prolific writer, producer and director with over three hundred hours of television programming to his credit. Berk created and Executive produced “Baywatch,” the most popular series in television history, and is currently producing a large-budget “Baywatch” feature film for Paramount.

Leslie Thomas is the marketing and operations manager for PNTV. Thomas works directly with major media outlets, including: Comcast Communications, DirecTV, AT&T, Verizon, and TivoCast, as well as multiple broadband sites.

The marketing and licensing advisor, John Raczka, has a proven track record of success in driving revenue growth in the linear, interactive and gaming entertainment sectors worldwide.

Edward Sullivan serves as the company’s media, branding, and marketing advisor. Sullivan has overseen the brand & marketing efforts for over 50 launches and re-launches of major media companies including: CBS, ABC, FOX, Discovery Networks, Turner Broadcasting, HBO and Disney cable networks.

Doug Miller serves on the board of PNTV and brings over thirty years of hands-on operating experience to the Players Network Board. Focusing on high growth start-up and turnaround companies, Mr. Miller participated in leading four companies to IPO´s. Mr. Miller holds a B.A. from the University of Nebraska and an MBA from Stanford University.


PNTV’s entrance into the medical marijuana market offers a lot of upside to current estimates, however the stock has not reacted favorably to this. PNTV is down over 10% since early November even though the story has improved. Technical420 thinks that the company has the potential to be player in the cannabis industry due to their unique business model and the synergies that can be created between Weed TV and Green Leaf Farms Holdings. However, the current trading pattern of PNTV keeps Technical420 on the sidelines until an upward price trend is formed, or until positive guidance is released regarding their Nevada operations.

1 343

Owning a Vending Machine Now One of the Most Popular New Business Ventures

Entrepreneurs have discovered the low cost of entry, ease of management, and high potential ROI

CORONA, Calif., Nov. 26, 2014 /PRNewswire/ — AVT, Inc. (OTC Markets: AVTC) (, a manufacturer of high performance automated retailing systems announced that they now offer entrepreneurs three distinct pathways to owning their own vending or automated retailing business.

The field of Automated Retailing (AR) has grown rapidly in recent years due to technological advances in the industry, and the affordability of starting a new AR business. Here are some key reasons why the industry is flourishing and why entrepreneurs are flocking to AR opportunities:

  1. Product Selection: Automated Retailing can provide consumers with a virtually limitless array of products in a convenient manner, without the need of a salesperson or waiting at a checkout line. The interesting products now available through automated retailing include: sunglasses, swimsuits, gourmet coffee, protein shakes, salads and healthy foods, clothing, electronics, iPods, digital cameras, cosmetics, and more. Automated Retailing can also provide services such as propane tank exchange, carpet cleaning rentals, and amazing new systems that clean and sanitize eyewear and jewelry. The bottom line: If there is something you want to sell, there is a machine that can automate the process.
  2. Ease of Management: New automated retailing systems provide wireless control and reporting, so entrepreneurs can monitor their systems from across town or across the country. Sales reports, inventory levels, and even demographic information can be downloaded in real time.
  3. Cost of Entry: One of the most compelling reasons that entrepreneurs are attracted to Automated Retailing is the low cost of ownership and ease of entry into the market. There are few other opportunities that offer such a turnkey system with a small investment. And while every AR opportunity is different, many have the potential to provide significant returns on investment.

AVT specializes in helping entrepreneurs start an Automated Retailing business. Some of the best-known and most highly acclaimed Automated Retailing businesses in the nation all got their start at AVT, including: HUMAN Healthy Vending, Medbox, Farmer’s Fridge, BurritoBox, plus the incredibly popular systems for fresh juice, caviar and cupcakes.

To find out more about how AVT provides entrepreneurs and business with opportunities to get into Automated Retailing, please visit the AVT website, at:, or call (877) 424-3663.

Media Inquiries:
Innovation Agency

To view the original version on PR Newswire, visit:

2 1719

There are very few people in the world that fall in the WW[BLANK]D category besides probably the big man himself. (Not Talking about Jesus Christ)

BUT investors around the world often find themselves asking ‘What Would Warren Buffett Do?’ just before or after making an investment.  Is it the right move for me? Will it make money? Should I take my profit or loss now?  All great questions but in the end I would say that it all comes back to the Oracle of Omaha himself.  So with that, What Would Warren Buffett Do in the case of an investment in marijuana stocks?



Big Buff’s Strategy 

To really grasp this to its fullest you really need to strip it down to the bare bones of Buffett’s investment fundamentals.  Warren Buffett is one of the richest men in the world. He built his fortune using a simple yet powerful investment strategy. His investments are long-term positions, accomplished by the purchase of strong companies that are trading well below their intrinsic value.  In a speech at Columbia Business School, later adapted into an essay, Buffett introduced what he called, “The Superinvestors of Graham-and-Doddsville.” (Benjamin Graham — whom Buffett studied under at Columbia — and Dave Dodd, with whom Graham wrote the book on security analysis…literally)


“The common intellectual theme of the investors from Graham-and-Doddsville is this: they search for discrepancies between the value of a business and the price of small pieces of that business in that market.”


In other words, Buffett doesn’t think about buying a stock; he thinks about buying a business. Buffett explains his thesis is based on the idea that the investors of Graham-and-Doddsville could care less about when they buy stocks, or be concerned about a stock’s beta or the “covariance in returns among securities.”


“These investors are businessmen buying pieces of businesses, not traders buying stocks.”


So when you think of it in a way of an acquisition based approach, the ideology of an investment versus the action of a trade takes a more profound meaning and with it, an entirely new sense of placing value on a stock and its underlying company.

Are Marijuana Stocks Warren’s ‘Pot’ of Gold?


Some would say that marijuana stocks could offer several key factors that Buffett looks for in the investments he makes.  For starters, Buffett relies on long-term trends and doesn’t necessarily concern himself with a bad quarter here or there. As long as business is growing and the product continues to “sell itself”, he is content (coming from a simplistic view of the WWWBD approach).  Banks, insurers, soft-drink makers, and railroads for example all benefit from a growing population that needs access to cash, ability to protect themselves from those unseen circumstances, and who can argue with Santa Claus pounding a glass bottle of Coke during the holidays?  When it comes to popular opinion, it would appear that as Americans, we’re all starting to look at weed the same way others look at Coca Cola…sure its loaded with sugar but “it’s not that bad.”


A recent Gallup poll conducted just prior to the midterm elections shows that “public support for legalizing the use of marijuana has clearly increased over the past decade.”  Furthermore “with a super-majority of younger Americans supportive — 64% of those aged 18 to 34, contrasted with 41% of those 55 and older — it seems inevitable that [legalization outside of more liberal states] will eventually change.”


Also in line with Buffett’s philosophy, price elasticity comes into play or rather the propensity for someone to buy a good regardless of price.  Marijuana could be seen as an inelastic commodity as so far it seems no matter what the price is, people are willing to buy.  Marijuana, in turn is something that at this point has a consistent demand unrelated to any other economic factors. Put another check mark in the “Buffett box”.


No Smoke, No Mirrors…Just Barriers


One thing that may not necessarily appeal to the Warren Buffett philosophy is the relatively easy road to getting involved in the marijuana industry.  Seemingly, it doesn’t appear that competition would be hot enough to have 4 or 5 major industry leaders to shake up the MJ space…just yet.


While rules and regulations definitely put up a wall when it comes to getting approved for a license (as a marijuana retailer), and patents would protect drugs developed by MJ companies focused on pharmaceutical applications, entering the marijuana industry isn’t all that hard…just look at the myriad companies already doing it in the penny stock market.


But here’s where the hook might be and it actually starts in the auto industry.  A recent article in Bloomberg Business Week cites that “In buying a chain of car dealerships, Buffett’s Berkshire Hathaway (BRK/B) sees plenty of moats (barriers to entry) and a clear path to consolidation.”


The industry is highly fragmented, for example the 10 largest U.S. dealers account for less than 10 percent of new vehicle sales (according to Morningstar). Buffett’s Berkshire Hathaway has plenty of opportunity to buy other dealers and help concentrate the industry This not only gives the company a cost advantage but by taking more of a “roll-up” approach, it gives pricing advantages as well.   Remember the reason why I said he might not like the industry?  Well it could be exactly why he should like it in the end.  In essence Buffett’s strategy would make him an industry leader that the market is currently lacking.


Could The Future Hold A Berkshire That Purports A Position in Pot?

Right now it’s probably not a likely avenue that this conglomerate would jump into.  We’re not even a year into the first legal recreational states reporting fiscal tax revenue nor is the country unanimously legalizing the drug.  It’s a very interesting scenario: You can go from Oregon to Washington with a joint and no one should seemingly care but the minute you cross into another state, you could potentially get put in jail for life!

WWWBD?  Probably stay far away from an investment where buyers of the product potentially face that kind of outcome.  So until the industry levels out, there is a clear track record of strong & consistent revenue, and until the industry is fully accepted in all states, I don’t foresee the ‘Oracle planning a portfolio strategy on marijuana stocks in the near future…but stranger things have happened so time will be the judge here in my opinion.

0 3094

“Green” Interest Returns

With the Elections behind us now and several more states “Going Green,” it is obvious that there will be a renewed interest in the Cannabis/Marijuana Sector of the MicroCap Market.  Investors learned some pretty tough lessons last year when they chased some of the sector related stocks up and grabbed positions during what can only be described as a parabolic move.  Now the hype is gone and so are most of the gains… what is left is a Market Sector littered with unfulfilled promises and disillusioned investors.  Gone are the dreams of early retirement and gone right along with those dreams are the portfolios with the inflated unrealized profits and balances stuffed with stocks of companies that never had any intentions of delivering anything of real value.  What is left is a Market Sector filled with a graveyard full of dead tickers along with a handful of real companies that will actually remain viable and execute on their business plan.

The State of Colorado alone estimates total Cannabis Sales for the next fiscal year could hit $160 million.  This projection leaves very little doubt that there is going to be renewed interest as well as a residual effect on the Public Markets.  The sixty-four dollar question is… how the hell do you navigate these shark infested waters without losing a leg or your shirt?  The answer to that is a simple one… become a realist and use some deductive reasoning. If a company is making a lot of forward looking statements, has a share structure that only a lonely broke Transfer Agent could love, and has a story that seems too good to be true… then it probably is.  The call of the day is DUE DILIGENCE! Read the filings, check out the Recent Headlines, look into the Share Structure, and pull up the chart… without completing all four of these due diligence actions then the best action for you to enter the Cannabis Sector of the market is …. NO ACTION.

With all of this being said, I want to briefly focus your attention in the direction of CannaGrow Holdings, Inc. OTC Pink (CGRW) formerly BizAuctions, Inc. This is a company that fits much of the criteria that was just hit upon.  Run it up the flagpole and see what you think.  It looks to me like a company that is not so much about selling stock as a business model but actually has plans to strategically enter the Medical/Recreational Cannabis Industry in the State of Colorado… without a marching band.  I kind of like that idea…..

In early June BizAuctions, Inc. issued a Corporate Update with hints of a change in their Business Model and then proceeded to quietly make several more moves that went virtually unnoticed by the market on a whole.  Here is what they did.

  1. Reduced the Authorized Shares of the company from 20,000,000,000 to 2,000,000,000
  2. Filed a Disclosure Statement and became completely current with their financials on
  3. Hired a top Law Firm in the Denver Area the specializes in the Medical/Recreational Cannabis Arena in the State of Colorado
  4. Leased an office in Centennial Colorado

Keep in mind there has been no Fanfare or horn blowing… all these steps were taken very quietly and methodically over about 30 days, so make a mental note of that.

Now here is where it starts to get really interesting… In Mid-July the Company hires a Consultant with a PhD in Botany and a Bachelor of Science in Agriculture.  Are you starting to get the picture yet?  Again, the Company is not making any wild claims or outlandish statements… just step by step methodical moves.

Next, they hire an Executive to oversee the new direction the Company has taken.  This new addition to the team has a Masters in Marketing and was the logistics manager of a 30,000 sq. ft. botanical and plant facility.  It doesn’t take a brain surgeon to stitch these pieces together.   This announcement was made at the end of July and the time period for all of these changes was only about 6 weeks.

Now the company goes quiet for a couple of months and the words “head fake” start to creep in as people who first noticed this story developing begin to question the all too familiar cessation of information.  Just when the silence becomes almost deafening the Company comes out with a couple of very significant announcements.  BizAuctions, Inc. has changed its name to CannaGrow Holdings, Inc. and submitted the change to Finra to take effect on November 1, 2014.  Then, as if right on queue, the Company releases press in regard to a signed Lease Agreement with NuGro Industries, Inc. for 20 acres in Huerfano County, CO.  The kicker to the Lease Agreement is NuGro Industries, Inc. agreed to build:

  • “State of the Art” 7,500 sq. ft. Greenhouse and Operations / Head-House
  • 6 – 1,800 sq. ft. Hoop Houses to accommodate 10,800 sq. ft. Summer Grows

Basically, The Lease calls for NuGro Industries to provide all of the development costs for the site plans, site work, utilities, and structures.  Did you get that?  CannaGrow Holdings, Inc. signed a Lease Agreement that calls for the Landlord to build to suit with some very specific terms.

On October 16, CannaGrow Holdings, Inc. adds to the ongoing saga by announcing yet another addition to the already experienced and knowledgeable “team grow”.  The new member to join the team has a Bachelor of Science in Agriculture and specializes in plant propagation.

So here is what we have.  A CEO that has 2 decades of experience in the public markets, a couple of experts in the area of agriculture, and an individual with extensive experience in greenhouse management.  This is a company has clearly entered into the Medical/Recreational Cannabis Arena in the State of Colorado without hype.  The stock has a very small float and is currently sitting at what appears to be a bottom that has been tested again and again over the last couple of months.

Let’s face it, with the move the whole Cannabis Sector saw last year and the subsequent sell off there is an abundance of skepticism that has been cast over the entire sector… as well there should be.  That brings us to an interesting question… How do we know what is real and what is… well for lack of a better word… not real?  My only suggestion is to adhere to these three words… research, research, research!  If you are going to invest hard earned money into what appears to be an industry boom, that is unparalleled since the California Gold Rush of the 1800’s or the Texas Oil Boom of the 1900’s, I encourage you to DO YOUR HOME WORK!!  Know what you are buying and don’t be deterred, you could soon join the ranks of the new Marijuana Millionaires…


CGRW Security Details

Share Structure

Market Value1 $12,707,343 a/o Nov 03, 2014
Shares Outstanding 127,073,434 a/o Oct 09, 2014
Float 25,762,901 a/o Oct 09, 2014
Authorized Shares 2,000,000,000 a/o Jul 07, 2014
Par Value 0.001


Cannagrow Holdings, Inc. (CGRW) Establishes Itself As a Leader In Colorado’s Expanding Cannabis Industry

BizAuctions — Shareholder Update

June 16, 2014

BizAuctions Files Notice of Corporate Action With FINRA

June 19

BizAuctions Files Disclosure Statements With OTC Markets

June 30, 2014

BizAuctions Executes Engagement Agreement With Hoban & Feola, LLC Law Firm in Denver, CO

July 11, 2014

BizAuctions-Signs Lease for Office in Centennial, Colorado

July 15, 2014

BizAuctions-Hires Consultant to Assist in Exploring Opportunities in Colorado

July 18, 2014

BizAuctions-Hires Executive to Oversee Expansion into Colorado

July 31, 2014

BizAuctions Files Name Change Amendment

October 3, 2014

BizAuctions-CannaGrow Executes 20 Acre Lease Agreement with NuGro Industries, Inc. for Lease in Huerfano County, Co.

October 9, 2014

Biz-CannaGrow Hires Consultant to Assist Dr. John Janovec with Colorado Cannabis Project

October 16, 2014

BizAuctions-Files Notice of Corporation Action with FINRA
October 23, 2014

2 2338 (Marijuana Stocks) is not validating and or discrediting the content below. We are simply publishing a story that is in our opinion very interesting & VERY controversial, to some. We want YOU to chime in below in our comment section and let us know what you think about this!

CBD Protective Against Ebola Virus

By David Allen M.D. Full Article Here:

“There is good scientific evidence that cannabinoids, and in particular Cannabidiol (CBD), may offer control of the immune system and in turn provide protection from viral infections (4). Cannabis has already been recognized to inhibit fungus and bacteria and can be considered a new class of antimicrobial because of the different mechanism of action from other antimicrobials.”


About David B. Allen M.D.
retired Cardiothoracic and Vascular Surgeon
Medical Director, Cannabis Sativa, Inc. (


References for the Article Written by David B. Allen M.D.

1)   Antibacterial Cannabinoids from Cannabis sativa: A Structure−Activity Study Antibacterial Cannabinoids from Cannabis sativa: A Structure−Activity Study; Giovanni Appendino et al. The School of Pharmacy, University of London

2)   Protection Against Septic Shock and Suppression of Tumor Necrosis Factor α and Nitric Oxide Production by Dexanabinol (HU-211), a Nonpsychotropic Cannabinoid Ruth Gallily1,
Aviva Yamin1, Departments of Immunology The Hebrew University, Faculty of Medicine, Jerusalem,  Rehovot, Israel.

3)    Cannabinoid derivatives US patent 20070179135 A1

4)    Treatment of HIV and diseases of immune dysregulation US 20080108647 A1

5)    Curr Pharm Des. 2006;12(24):3135-46. Cannabinoids, immune system and cytokine network. Massi PVaccani AParolaro D, University of Insubria, Via A. da Giussano 10, 21052 Busto Arsizio (VA), Italy

6)    Cancer Res August 15, 2004 64; 5617 Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas Cristina Blázquez HYPERLINK “”1,

7)    How Cannabis Might Keep Coronary Stents Open Longer…/how-cannabis-might-keep-coronary-stents-open-longer
Jun 10, 2014 David Allen M.D.

0 1001

Yep, It’s Really Happening…

3D printing and the unlimited potential of what they could possibly do has been a hot topic for quite a while now. People have been talking for years about how the use of 3D printers could exponentially reduce the time it takes for creating prototypes for industrial parts and not to mention the money that could be saved.

All of those things are really just the tipping point as to what is possible with 3D printing. Imagine someday being able to end world hunger with the printing of food, or saving lives by printing human organs.

An Israeli company is already merging the aspects of 3D printing and therapeutics.

In a recent report by Forbes, Syqe Medical has been working to develop a pocked sized, 3D printed inhaler. The inhaler could be used to accurately dose medical marijuana patients with cannabis. Syge Medical has taken things a step further and all devices will be enabled with Wi-Fi technology so that doctors can connect in real time to monitor and ensure accurate levels of dosing.

The report goes on to mention Stratasys (NASDAQ: SSYS), who is one of the world’s largest 3D printing companies. Stratasys is the company responsible for engineering about three-quarters of the 3D printed parts for the inhaler. Using the fact that 3F printing is still fairly new, Stratasys was able to accelerate delivery of these inhaler parts well ahead of schedule.

Possibly even more interesting than the gaining popularity of 3D printing, is the concept of marijuana patients accurately being able to be potentially dosed with such exact doses of cannabis. Syqe Medical hopes that by making the dose specific and easy to administer, that they will be able to persuade the public, physicians, and perhaps regulatory agencies around the globe that the product is a safe and effective form of dosing cannabis.

As interesting as it is, there is definitely still a long way to go. While advancements continue to happen, the possibility of this happening for patients in the US is most likely a long way off.

The challenges that medical marijuana faces in the US are numerous. It still remains a schedule 1 drug, as determined by the Drug Enforcement Agency. That makes it more of a challenge to gain broader approval for medical use nationwide.

Another challenge is that it has yet to be determined by the U.S. Food and Drug Administration and doctors as to if medical marijuana could ever be considered a mainstream therapy.

Lastly, the long term affects of using marijuana change depending on what the source of the information is. While there is a lot of  potential for cannabis as a therapeutic source, the timeframe in which people want to see it because mainstream may be a lot longer than people want.


0 317

Good Find from ABC News

The entrepreneurs of the young U.S. marijuana industry are taking another step into the mainstream, becoming political donors who use some of their profits to support cannabis-friendly candidates and ballot questions that could bring legal pot to more states.

The political activity includes swanky fundraisers at Four Seasons hotels and art auctions at law firms. And members of Congress who once politely returned the industry’s contribution checks are now keeping them.

“We’re developing an industry here from the ground up. If we don’t contribute politically and get out there with the candidates, we can’t help shape what happens,” said Patrick McManamon, head of Cleveland-based Cannasure Insurance Services, which offers insurance to marijuana growers and dispensaries.

Medical marijuana businesses have been giving to candidates since the late 1990s. With the arrival of recreational pot in Colorado and Washington, the industry and its political influence are expanding rapidly.

Pot is now legal for medical or recreational purposes in 23 states and Washington, D.C. More marijuana measures will be on the November ballot in Oregon, Florida, Alaska and the nation’s capital, so many contributions are being funneled into those campaigns and the candidates who support them.

Compared with the donations of other industries or advocacy groups, the political spending by marijuana businesses is modest. But, said Tripp Keber, head of Denver-based Dixie Elixirs & Edibles, which makes pot-infused soda, food and lotion, “the word is out that the marijuana industry has money to give.”

Keber attended a summer fundraiser for Colorado Gov. John Hickenlooper, who opposed legalization in 2012 but has promised to regulate the industry according to voters’ wishes.

“It was interesting to see how he’s starting to evolve. I said, ‘I’m telling you, I can get 100 people in the room who would be happy to max out,'” or give the state’s maximum legal donation of $1,100, Keber said.

A few weeks later, in August, Keber threw a fundraiser at the Four Seasons in Denver with a goal of raising $16,000 for Hickenlooper. The event netted $40,000.

In Washington state, the industry’s contributions are channeled into reforms that include reducing the tax rate on pot and kicking some marijuana revenue back to cities and counties to encourage more communities to allow dispensaries, said dispensary owner John Davis, who also serves as director of the Coalition for Cannabis Standards and Ethics.

Not long ago, most marijuana entrepreneurs were “trying to scrape a few dollars together” to get started, Keber said. “Now this industry is becoming profitable, and we’re taking that profit and investing it politically. There isn’t a week that goes by where we don’t make a political donation.”

The Oregon ballot measure has raised about $2.3 million. A medical-marijuana question in Florida has attracted nearly $6 million. And the Alaska campaign has brought in about $850,000. A recreational pot measure in Washington, D.C., attracted few donations, perhaps because it appears almost certain to pass.

Colorado’s congressional delegation alone has received some $20,000 this year from the marijuana industry, according to federal campaign-finance data. The true figure is probably much higher because many donors do not mention the drug in campaign-finance disclosures.

The largest federal spender on marijuana advocacy is the Marijuana Policy Project, which plans to donate $150,000 to federal candidates this year, up from $110,000 in 2013. The Drug Policy Alliance and the National Organization for the Reform of Marijuana Laws have also given directly to federal candidates, and tax-exempt industry groups such as the National Cannabis Industry Association can spend an unlimited amount of untracked money.

Politicians who used to reject checks from pro-marijuana donors “aren’t doing that anymore,” said Ethan Nadelmann, head of the New York-based Drug Policy Alliance.

Still, the same candidates who cash the checks aren’t always keen to talk about it. About a dozen recipients of marijuana money declined interview requests or did not return calls from The Associated Press.

A Colorado state lawmaker who accepts marijuana-industry donations conceded thinking twice before taking them.

“I always worry about what people’s perceptions will be,” said Rep. Jonathan Singer, a Democrat who is the only sitting Colorado legislator who supported legalization. “But it came down to, I’m on record for where I stood before I ever took a penny from this industry.”

Todd Mitchem, a Denver marijuana industry consultant, recalled a fundraiser earlier this year thrown by a maker of cannabis vaporizer cartridges for a state legislator. When the company posted photos from the event on its Facebook page, the lawmaker asked that the images be taken down.

“They just didn’t want to be seen. They were still taking the money,” said Mitchem, who declined to name the lawmaker.

The only member of Congress who responded to the AP was Colorado Democratic Rep. Jared Polis, a longtime ally of the marijuana industry who has proposed federal legalization.

“As long as this industry Is following our state marijuana laws,” Polis said in a statement, “their contributions are the same as those from any other legal donors.”


Associated Press writers Nigel Duara in Portland, Oregon; Becky Bohrer in Juneau, Alaska; Ben Nuckols in Washington, D.C.; Gene Johnson in Seattle and Brendan Farrington in Tallahassee, Florida, contributed to this report.


Kristen Wyatt can be reached at .